Managing Partner at Meru Advisors. Over 20 years’ experience as an investor relations, corporate communications, operations, and corporate finance executive. Focus on biotech and the life sciences.

Solebury Trout partners with private and public companies across sectors, helping management teams tackle complex investor relations challenges, capitalize on corporate communications opportunities, access the market and prepare for capital raising. More than 60 professionals with expertise in investor relations, equity research, portfolio management, private equity, investment banking and corporate communications work at Solebury Trout. The company was formed through the combination of Solebury Communications with the Trout Group, the premier investor relations and strategic advisory firm serving the biotechnology industry, providing corporate access and hosting dozens of well-attended conferences and thought leader events. Solebury Trout is affiliated with leading equity capital markets advisory firm Solebury Capital, which in 2017 advised on nearly 40 percent of the IPO proceeds in the U.S., and is owned by PNC, one of the largest diversified financial institutions in the country.

Advise public and private life sciences clients on capital raising strategy. Experience with IPOs, secondary offerings, PIPEs, registered direct offerings and private placements. Co-founded and launched Trout Capital in 2004, managing the set-up process start to finish, including discussions with internal and external counsel, FINRA and additional service providers, and overseeing compliance.

Committee member of Angel Fund created to connect Wharton Executive MBA classmates and to support early stage businesses with a focus on those originating from Wharton MBAs. Fund's mission is to build a strong membership base by engaging our members in investment decisions, and selectively supporting attractive investments.If you would like to contact the WEMBA 38 Investment Club, please contact Wemba38Angels@gmail.com

Deliver strategic and investor relations counsel with a focus on strategic objectives, investor targeting, corporate messaging and communications strategy, clinical data discussions, investor diligence, capital raising and capital markets for clients of the firm.